Multiple sclerosis (MS) is an autoimmune, inflammatory neurodegenerative disease of the
central nervous system characterized by demyelination and axonal damage. Diagnosis and …

Biomarkers can be thought of as multifaceted indicators of healthy status or of pathological
disorders. The study of multiple sclerosis can benefit from the use of biomarkers because of …

Neurodegeneration is the correlate of disease progression in multiple sclerosis (MS) and
thus biological biomarkers that sensitively reflect this process are much needed …

Multiple sclerosis (MS) is a severe disease of the central nervous system (CNS)
characterized by autoimmune inflammation and neurodegeneration. Historically, damage to …

Maintaining the appropriate complement and content of lipids in cellular membranes is
critical for normal neural function. Accumulating evidence suggests that even subtle …

Multiple sclerosis (MS) is an autoimmune disorder of the brain and spinal cord that
predominantly affects white matter. MS has a variable clinical presentation and has no …

The immune system is inextricably linked with many neurodegenerative diseases including
amyotrophic lateral sclerosis (ALS), a devastating neuromuscular disorder affecting motor …

Drainage of central nervous system (CNS) antigens to the brain-draining cervical lymph
nodes (CLN) is likely crucial in the initiation and control of autoimmune responses during …

Multiple sclerosis (MS) is an autoimmune disease of unknown cause, in which chronic
inflammation drives multifocal demyelination of axons in both white and gray matter in the …

Multiple sclerosis (MS) is an inflammatory disorder of the central nervous system (CNS) with
heterogeneous clinical, genetic and pathophysiological characteristics. The establishment of …